However, during the regular monitoring of tumor markers, the carcinoembryonic antigen (CEA) showed an abnormal result on 11 February 2023 (19.49 ng/mL), and further increased to 28.24 ng/mL on 21 March 2023, suggesting a biochemical recurrence. Here, CEACAM5 is linked to neoplasm.